163 related articles for article (PubMed ID: 29863178)
1. Mediastinal lymphadenectomy for esophageal cancer: Differences between two countries, Japan and the Netherlands.
Cuesta MA; van der Peet DL; Gisbertz SS; Straatman J
Ann Gastroenterol Surg; 2018 May; 2(3):176-181. PubMed ID: 29863178
[TBL] [Abstract][Full Text] [Related]
2. The extent of lymphadenectomy in esophageal resection for cancer should be standardized.
Hagens ERC; van Berge Henegouwen MI; Cuesta MA; Gisbertz SS
J Thorac Dis; 2017 Jul; 9(Suppl 8):S713-S723. PubMed ID: 28815067
[TBL] [Abstract][Full Text] [Related]
3. Ways and tradition of Japan in esophageal surgery for cancer.
Fujita H
Gen Thorac Cardiovasc Surg; 2020 Oct; 68(10):1187-1192. PubMed ID: 32350784
[TBL] [Abstract][Full Text] [Related]
4. Safety and Feasibility of Robot-Assisted Minimally Invasive Esophagectomy (RAMIE) with Three-Field Lymphadenectomy and Neoadjuvant Chemoradiotherapy in Patients with Resectable Esophageal Cancer and Cervical Lymph Node Metastasis.
van der Horst S; Weijs TJ; Braunius WW; Mook S; Mohammed NH; Brosens L; van Rossum PSN; Weusten BLAM; Ruurda JP; van Hillegersberg R
Ann Surg Oncol; 2023 May; 30(5):2743-2752. PubMed ID: 36707482
[TBL] [Abstract][Full Text] [Related]
5. Impact of Extent of Lymphadenectomy on Survival, Post Neoadjuvant Chemotherapy and Transthoracic Esophagectomy.
Phillips AW; Lagarde SM; Navidi M; Disep B; Griffin SM
Ann Surg; 2017 Apr; 265(4):750-756. PubMed ID: 27467444
[TBL] [Abstract][Full Text] [Related]
6. [Optimal lymphadenectomy for thoracic esophageal cancer: three-field or modified two-field lymphadenectomy].
Liu S; Wang Z; Wang F
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Sep; 19(9):975-978. PubMed ID: 27680062
[TBL] [Abstract][Full Text] [Related]
7. Optimal lymphadenectomy for squamous cell carcinoma in the thoracic esophagus: comparing the short- and long-term outcome among the four types of lymphadenectomy.
Fujita H; Sueyoshi S; Tanaka T; Fujii T; Toh U; Mine T; Sasahara H; Sudo T; Matono S; Yamana H; Shirouzu K
World J Surg; 2003 May; 27(5):571-9. PubMed ID: 12715226
[TBL] [Abstract][Full Text] [Related]
8. Improvement Effect of Upper Mediastinal Lymphadenectomy During Minimally Invasive Esophagectomy on the Prognosis in Squamous Cell Carcinoma: Efficacy Index and Propensity Score Matching Analyses.
Oshikiri T; Goto H; Kato T; Hasegawa H; Kanaji S; Yamashita K; Fujino Y; Tominaga M; Matsuda T; Kakeji Y
J Am Coll Surg; 2023 Nov; 237(5):762-770. PubMed ID: 37366544
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Neoadjuvant Chemoradiotherapy Following Esophagectomy with Japanese-style Extended 3-Field Lymphadenectomy for Thoracic Esophageal Cancer.
Motoyama S; Sato Y; Sasaki T; Wakita A; Kawakita Y; Liu J; Nagaki Y; Saito H; Imai K; Konno H; Mizusawa KT; Minamiya Y
Anticancer Res; 2017 Oct; 37(10):5837-5843. PubMed ID: 28982909
[TBL] [Abstract][Full Text] [Related]
10. Impact of Lymph Node Yield on Overall Survival in Patients Treated With Neoadjuvant Chemoradiotherapy Followed by Esophagectomy for Cancer: A Population-based Cohort Study in the Netherlands.
Visser E; van Rossum PSN; Ruurda JP; van Hillegersberg R
Ann Surg; 2017 Nov; 266(5):863-869. PubMed ID: 28742691
[TBL] [Abstract][Full Text] [Related]
11. Distribution of lymph node metastases in esophageal carcinoma [TIGER study]: study protocol of a multinational observational study.
Hagens ERC; van Berge Henegouwen MI; van Sandick JW; Cuesta MA; van der Peet DL; Heisterkamp J; Nieuwenhuijzen GAP; Rosman C; Scheepers JJG; Sosef MN; van Hillegersberg R; Lagarde SM; Nilsson M; Räsänen J; Nafteux P; Pattyn P; Hölscher AH; Schröder W; Schneider PM; Mariette C; Castoro C; Bonavina L; Rosati R; de Manzoni G; Mattioli S; Garcia JR; Pera M; Griffin M; Wilkerson P; Chaudry MA; Sgromo B; Tucker O; Cheong E; Moorthy K; Walsh TN; Reynolds J; Tachimori Y; Inoue H; Matsubara H; Kosugi SI; Chen H; Law SYK; Pramesh CS; Puntambekar SP; Murthy S; Linden P; Hofstetter WL; Kuppusamy MK; Shen KR; Darling GE; Sabino FD; Grimminger PP; Meijer SL; Bergman JJGHM; Hulshof MCCM; van Laarhoven HWM; Mearadji B; Bennink RJ; Annema JT; Dijkgraaf MGW; Gisbertz SS
BMC Cancer; 2019 Jul; 19(1):662. PubMed ID: 31272485
[TBL] [Abstract][Full Text] [Related]
12. Minimally Invasive Esophagectomy with Thoracic Duct Resection Post Neoadjuvant Chemoradiotherapy for Carcinoma Esophagus-Impact on Lymph Node Yield and Hemodynamic Parameters.
Anand S; Kalayarasan R; Chandrasekar S; Gnanasekaran S; Pottakkat B
J Gastrointest Cancer; 2019 Jun; 50(2):230-235. PubMed ID: 29344808
[TBL] [Abstract][Full Text] [Related]
13. The Value of Paratracheal Lymphadenectomy in Esophagectomy for Adenocarcinoma of the Esophagus or Gastroesophageal Junction: A Systematic Review of the Literature.
Gantxegi A; Kingma BF; Ruurda JP; Nieuwenhuijzen GAP; Luyer MDP; van Hillegersberg R
Ann Surg Oncol; 2022 Feb; 29(2):1347-1356. PubMed ID: 34845567
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of lymphadenectomy for lymph node recurrence after esophagectomy or definitive chemoradiotherapy for squamous cell carcinoma of the esophagus.
Watanabe M; Mine S; Yamada K; Shigaki H; Baba Y; Yoshida N; Kajiyama K; Yamamoto N; Sano T; Baba H
Gen Thorac Cardiovasc Surg; 2014 Nov; 62(11):685-92. PubMed ID: 24965711
[TBL] [Abstract][Full Text] [Related]
15. Clinical Impact of the Location of Lymph Node Metastases After Neoadjuvant Chemotherapy for Middle and Lower Thoracic Esophageal Cancer.
Miyata H; Sugimura K; Yamasaki M; Makino T; Tanaka K; Morii E; Omori T; Yamamoto K; Yanagimoto Y; Yano M; Nakatsuka S; Mori M; Doki Y
Ann Surg Oncol; 2019 Jan; 26(1):200-208. PubMed ID: 30374924
[TBL] [Abstract][Full Text] [Related]
16. Role of right upper mediastinal lymph node metastasis in patients with esophageal squamous cell carcinoma after tri-incisional esophagectomies.
Hsu PK; Huang CS; Hsieh CC; Wu YC; Hsu WH
Surgery; 2014 Nov; 156(5):1269-77. PubMed ID: 24953277
[TBL] [Abstract][Full Text] [Related]
17. [Neoadjuvant chemoradiotherapy or chemotherapy for locally advanced esophageal cancer?].
Babic B; Fuchs HF; Bruns CJ
Chirurg; 2020 May; 91(5):379-383. PubMed ID: 32140748
[TBL] [Abstract][Full Text] [Related]
18. Comparison of mediastinal lymph node metastases from adenocarcinoma of the esophagogastric junction versus lower esophageal squamous cell carcinoma with involvement of the esophagogastric junction.
Mine S; Watanabe M; Kumagai K; Okamura A; Yuda M; Hayami M; Yamashita K; Imamura Y; Ishizuka N
Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30791046
[TBL] [Abstract][Full Text] [Related]
19. Impact of Surgical Approach on Long-term Survival in Esophageal Adenocarcinoma Patients With or Without Neoadjuvant Chemoradiotherapy.
Noordman BJ; van Klaveren D; van Berge Henegouwen MI; Wijnhoven BPL; Gisbertz SS; Lagarde SM; van der Gaast A; Hulshof MCCM; Biermann K; Steyerberg EW; van Lanschot JJB;
Ann Surg; 2018 May; 267(5):892-897. PubMed ID: 28350565
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trial.
von Döbeln GA; Klevebro F; Jacobsen AB; Johannessen HO; Nielsen NH; Johnsen G; Hatlevoll I; Glenjen NI; Friesland S; Lundell L; Yu J; Nilsson M
Dis Esophagus; 2019 Feb; 32(2):. PubMed ID: 30137281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
